The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy.

Autor: Garcia-Recio M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Wudhikarn K; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Division of Hematology and Research Unit in Translational Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Pennisi M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Oncology and Onco-Hematology Department, University of Milan, Milan, Italy; Hematology Service, Oncology and Hematology Department, Instituto Nazionale dei Tumori, Milan, Italy., Alonso-Trillo R; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Hematology Service, Hospital Puerta de Hierro, Majadahonda, Spain., Flynn J; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Shouval R; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Afuye AO; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Silverberg ML; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Batlevi CW; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York., Dahi P; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York., Devlin S; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Giralt SA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York., Halton E; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Ruiz J; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Maloy M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Mead E; Neurology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York., Palomba ML; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York., Santomasso B; Neurology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York., Sauter CS; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York., Scordo M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York., Shah GL; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York., Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Intensive Care Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College; New York, New York. Electronic address: peralesm@mskcc.org.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2021 Mar; Vol. 27 (3), pp. 233-240. Date of Electronic Publication: 2020 Dec 18.

Paradigms for Precision Medicine in Epichaperome Cancer Therapy.

Autor: Pillarsetty N; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Jhaveri K; Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Taldone T; Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA., Caldas-Lopes E; Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA., Punzalan B; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Joshi S; Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA., Bolaender A; Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA., Uddin MM; Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA., Rodina A; Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA., Yan P; Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA., Ku A; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Ku T; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Shah SK; Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA., Lyashchenko S; Radiochemistry and Molecular Imaging Probes Core, Sloan Kettering Institute, New York, NY 10065, USA., Burnazi E; Radiochemistry and Molecular Imaging Probes Core, Sloan Kettering Institute, New York, NY 10065, USA., Wang T; Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA., Lecomte N; Gastrointestinal Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Janjigian Y; Gastrointestinal Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Younes A; Lymphoma Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Batlevi CW; Lymphoma Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Guzman ML; Division of Hematology and Medical Oncology, Leukemia Program, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY 10065, USA., Roboz GJ; Division of Hematology and Medical Oncology, Leukemia Program, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY 10065, USA., Koziorowski J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Zanzonico P; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Alpaugh ML; Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA., Corben A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Modi S; Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Norton L; Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Larson SM; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Program in Molecular Pharmacology, Sloan Kettering Institute, New York, NY 10065, USA., Lewis JS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Program in Molecular Pharmacology, Sloan Kettering Institute, New York, NY 10065, USA., Chiosis G; Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA. Electronic address: chiosisg@mskcc.org., Gerecitano JF; Lymphoma Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Dunphy MPS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: dunphym@mskcc.org.

Publikováno v: Cancer cell [Cancer Cell] 2019 Nov 11; Vol. 36 (5), pp. 559-573.e7. Date of Electronic Publication: 2019 Oct 24.

Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy.

Autor: Winkelmann, Michael¹, Blumenberg, Viktoria^2,3,4, Rejeski, Kai^2,3,4, Bücklein, Veit L.^2,3,4, Ruzicka, Michael⁴, Unterrainer, Marcus¹, Schmidt, Christian⁴, Dekorsy, Franziska J.⁵, Bartenstein, Peter^5,6, Ricke, Jens^1,6, von Bergwelt-Baildon, Michael^4,6, Subklewe, Marion^2,3,4, Kunz, Wolfgang G.^1,6 wolfgang.kunz@med.lmu.de

Publikováno v: European Journal of Nuclear Medicine & Molecular Imaging. Apr2023, Vol. 50 Issue 5, p1406-1413. 8p. 1 Diagram, 2 Charts, 2 Graphs.

Seropositivity against vaccine preventable infections in the early post chimeric antigen receptor T-cell period: Preservation of vaccine-associated antibodies between 0 and 6 months.

Autor: Reynolds GK; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases and Immunology, Austin Health, Melbourne, Victoria, Australia., Klimevski E; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Saunders NR; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Teenakoon GS; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Harrison SJ; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Dowling M; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Anderson MA; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute, Melbourne, Victoria, Australia., Thursky K; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Slavin MA; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Teh BW; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Oct 27. Date of Electronic Publication: 2024 Oct 27.

Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel.

Autor: Mian A; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA., Wei W; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA., Hamilton BK; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Winter AM; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Khouri J; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Pohlman B; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Gerds AT; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Jagadeesh D; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Anwer F; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Kalaycio M; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Dean RM; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Sobecks R; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Caimi PF; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Hill BT; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Majhail NS; Sarah Cannon, Nashville, TN, USA. navneet.majhail@sarahcannon.com.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2023 May; Vol. 58 (5), pp. 590-593. Date of Electronic Publication: 2023 Feb 11.